Armstrong Henry H Associates Inc / JNJ
Armstrong Henry H Associates Inc’s Johnson & Johnson Position
Does Armstrong Henry H Associates Inc own Johnson & Johnson (JNJ)? Yes — 322.9K shares worth $82M (+7.94% of its 13F portfolio) as of Q2 2026, up from 320.1K shares the prior filed quarter.
Position Value
$82M
Q2 2026
Shares
322.9K
% of Portfolio
+7.94%
Quarters Held
31
currently held
Position History JNJ
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 322.9K | $82M | +7.94% |
| Q1 2026 | 320.1K | $78M | +7.97% |
| Q4 2025 | 320.8K | $66M | +6.17% |
| Q3 2025 | 327.8K | $61M | +5.50% |
| Q2 2025 | 330.5K | $50M | +4.76% |
| Q1 2025 | 346.1K | $57M | +5.56% |
| Q4 2024 | 350.7K | $51M | +5.07% |
| Q3 2024 | 360.0K | $58M | +5.59% |
| Q2 2024 | 741.6K | $113M | +5.57% |
| Q1 2024 | 375.8K | $59M | +5.78% |
| Q4 2023 | 380.3K | $60M | +6.33% |
| Q3 2023 | 390.3K | $61M | +6.94% |
| Q2 2023 | 393.3K | $65M | +7.19% |
| Q1 2023 | 400.5K | $62,075 | +7.56% |
| Q4 2022 | 413.7K | $73,084 | +9.06% |
| Q3 2022 | 418.8K | $68M | +9.27% |
| Q2 2022 | 416.5K | $74M | +9.33% |
| Q1 2022 | 413.4K | $73M | +7.73% |
| Q4 2021 | 419.0K | $72M | +7.52% |
| Q3 2021 | 423.7K | $68M | +7.92% |
| Q2 2021 | 424.9K | $70M | +8.04% |
| Q1 2021 | 424.3K | $70M | +8.59% |
| Q4 2020 | 425.5K | $67M | +8.82% |
| Q3 2020 | 429.9K | $64M | +8.87% |
| Q2 2020 | 433.3K | $61M | +9.13% |
| Q1 2020 | 434.3K | $60M | +9.94% |
| Q4 2019 | 430.3K | $63M | +9.04% |
| Q3 2019 | 432.1K | $56M | +9.17% |
| Q2 2019 | 434.5K | $61M | +8.27% |
| Q1 2019 | 484.0K | $68M | +10.44% |
| Q4 2018 | 492.2K | $64M | +10.43% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Armstrong Henry H Associates Inc’s full portfolio or all institutional holders of JNJ.